+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Forecast 2024-2030- Product Image
Global Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Forecast 2024-2030- Product Image
Sale

Global Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Forecast 2024-2030

  • PDF Icon

    Report

  • 197 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5292895
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Anti-Mullerian Hormone Test Market size was estimated at USD 274.26 million in 2023, USD 305.41 million in 2024, and is expected to grow at a CAGR of 11.46% to reach USD 586.48 million by 2030.

Anti-Mullerian hormone (AMH) tests are diagnostic tools used to measure the levels of anti-Mullerian hormone, a protein hormone produced by granulosa cells in ovarian follicles. The AMH test provides details about the women's ovarian reserve and estimates the remaining quantity of eggs and potential fertility. In reproductive medicine, these tests are used to assess conditions such as polycystic ovary syndrome (PCOS) and primary ovarian insufficiency (POI). Moreover, AMH tests are used in vitro fertilization (IVF) for medication dosing and predicting ovarian response to stimulation.

The rising awareness and incidence of reproductive health issues, the growing need for early and accurate diagnosis of fertility and ovarian health, and the increasing age of first-time pregnancies across the world necessitate fertility assessments, which are accomplished by using AMH testing. In addition, advancements in diagnostic technologies and the expansion of healthcare infrastructure globally increase the accessibility and affordability of these tests. However, limited awareness of AMH tests in low-resource settings hinders their penetration. Moreover, the high cost of these tests and the need for standardized testing protocols across different regions can further complicate their access and consistent adoption in healthcare outcomes. Technological integration to interpret AMH levels and related fertility factors is expected to present a significant opportunity for the growth of the AMH test market.

Regional Insights

Asia-Pacific is exhibiting a rapid increase in awareness and need for reproductive health services, including the anti-Mullerian hormone (AMH) test, primarily attributed to the growing healthcare expenditures and a notable shift in consumer behavior toward preventive healthcare measures. The higher incidence of polycystic ovary syndrome (PCOS) and infertility issues among women and the evolving healthcare system have supported the need for AMH test procedures. In the Americas, the anti-Mullerian hormone test market is driven by advanced healthcare infrastructure, high awareness levels regarding reproductive health, and substantial investment in research and development.

Consumer behavior in the region is characterized by a proactive approach to fertility testing, where individuals are inclined toward early diagnosis and treatment. Europe, the Middle East, and Africa represent a highly diverse market for the AMH test, with varying degrees of adoption across the region. Western European countries feature high consumer awareness and a well-established healthcare system supporting reproductive health services. However, Eastern European nations are gradually emerging, propelled by enhancing healthcare infrastructures and policies. The Middle East exhibits a burgeoning healthcare sector, where countries invest heavily in medical tourism, including fertility services. Africa is at a nascent stage and is showing promise with increasing private and public sector initiatives aimed at enhancing women's healthcare services, including fertility testing.

Market Trends by Segment

  • Product: Increasing consumer preference for POC testing to obtain professional oversight
  • End-User: Rising penetration of AMH test kits in commercial labs for accurate and rapid results
  • Distribution: Emerging availability of AMH testing kits on online channels
  • Use: Significant usage of AMH testing kits for human applications

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Introduction of Novel Assay by Siemens Healthineers' for Assessing Ovarian Reserve

Siemens Healthineers introduced an anti-Mullerian hormone (AMH) assay, a significant development for laboratories specializing in reproductive endocrinology, offering a fast and reliable method for evaluating a woman's ovarian reserve. This test is instrumental for physicians in determining the feasibility of commencing in vitro fertilization (IVF) treatments. The new product launch emphasized the importance of ovarian reserve knowledge in empowering patients and doctors to make informed decisions about IVF, facilitating a more efficient and patient-centric approach to overcome fertility challenges.

The Introduction of MenoCheck by ARUP Laboratories to Revolutionizing Menopausal Management

ARUP Laboratories advanced the management of menopause through the introduction of MenoCheck, a breakthrough immunoassay developed by Ansh Labs. This clinically validated and FDA-cleared test represents a major step forward in accurately determining menopausal status, using the detection of ultralow concentrations of anti-Mullerian hormone (AMH) as a reliable indicator of ovarian reserve.

The Advent of the Elecsys Anti-Müllerian Hormone Plus immunoassay for Enhanced Accessibility and Early Detection

Roche Diagnostics achieved a significant milestone with the CE mark approval for a claim extension to the Elecsys anti-Mullerian hormone (AMH) Plus immunoassay, enabling this blood test as a viable alternative for diagnosing polycystic ovary syndrome (PCOS), representing a departure from the traditional transvaginal ultrasound method. This breakthrough paves the way for earlier and comfortable diagnostic experiences, ultimately fostering targeted therapeutic interventions and lifestyle adjustments to mitigate PCOS's reproductive, metabolic, and psychological impacts.

Key Company Profiles

The report delves into recent significant developments in the Anti-Mullerian Hormone Test Market, highlighting leading vendors and their innovative profiles. These include Abbexa Limited, Abcam PLC, Ansh Labs LLC, Athenese-Dx, Beckman Coulter, Inc. by Danaher Corporation, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, bioMérieux S.A., BioVendor - Laboratorni Medicina A.S., Chengdu VACURE Biotechnology Co., Ltd., CTK Biotech, Inc., Cusabio Technology LLC, Eagle Biosciences, Inc., Elabscience Bionovation Inc., Epitope Diagnostics, Inc., F. Hoffmann-La Roche Ltd., Fujirebio Europe N.V. by H.U. Group Holdings, Inc., Goldsite Diagnostics Inc., Healthy Human Labs Limited (Vitall), Kamiya Biomedical Company, LifeSpan BioSciences, Inc., London Gynaecology Limited, Meridian Bioscience, Inc., Monobind Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Tosoh Corporation, and Vitrosens Biotechnology Co., Ltd.

This research report offers invaluable insights into various crucial aspects of the Anti-Mullerian Hormone Test Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of polycystic ovary syndrome worldwide
5.1.1.2. Growing number of IVF and egg-freezing procedures
5.1.2. Restraints
5.1.2.1. Limited reimbursements available for AMH tests
5.1.3. Opportunities
5.1.3.1. Advancements in anti-Mullerian hormone test technology
5.1.3.2. Government initiatives for creating awareness associated with reproductive and infertility treatment health
5.1.4. Challenges
5.1.4.1. Inconsistencies and false results associated with anti-Mullerian hormone kits
5.2. Market Segmentation Analysis
5.2.1. Product: Increasing consumer preference for POC testing to obtain professional oversight
5.2.2. End-User: Rising penetration of AMH test kits in commercial labs for accurate and rapid results
5.2.3. Distribution: Emerging availability of AMH testing kits on online channels
5.2.4. Use: Significant usage of AMH testing kits for human applications
5.3. Market Trend Analysis
5.3.1. Strong healthcare infrastructure for infertility treatment and presence of established AMH test providers in the Americas
5.3.2. Rise of new IVF clinics in Asia-Pacific and increasing adoption of AMH tests
5.3.3. Increasing consumer awareness toward egg freezing treatments and development of novel AMH testing kits in EMEA
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework Analysis
6. Anti-Mullerian Hormone Test Market, by Product
6.1. Introduction
6.2. POC Testing
6.3. Self-check Kits
7. Anti-Mullerian Hormone Test Market, by End-User
7.1. Introduction
7.2. Commercial Labs
7.3. Research & development
8. Anti-Mullerian Hormone Test Market, by Distribution
8.1. Introduction
8.2. Offline Channels
8.3. Online Channels
9. Anti-Mullerian Hormone Test Market, by Use
9.1. Introduction
9.2. Human
9.3. Non-Human Primate
10. Americas Anti-Mullerian Hormone Test Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Anti-Mullerian Hormone Test Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Anti-Mullerian Hormone Test Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Introduction of Novel Assay by Siemens Healthineers' for Assessing Ovarian Reserve
13.3.2. The Introduction of MenoCheck by ARUP Laboratories to Revolutionizing Menopausal Management
13.3.3. The Advent of the Elecsys Anti-Müllerian Hormone Plus immunoassay for Enhanced Accessibility and Early Detection
13.3.4. Innovative At-Home Fertility Test by Fertilly for Understanding Reproductive Health through Anti-Müllerian Hormone Analysis
13.3.5. Strategic Acquisition of Meridian Bioscience by SD Biosensor and SJL Partners for Enhanced Growth and Global Impact
13.3.6. Randox Quality Control Introduces Advanced Acusera AMH Control for Enhanced Reproductive Testing
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. ANTI-MULLERIAN HORMONE TEST MARKET RESEARCH PROCESS
FIGURE 2. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 4. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 6. ANTI-MULLERIAN HORMONE TEST MARKET DYNAMICS
FIGURE 7. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 9. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 10. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 11. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 13. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2023 VS 2030 (%)
FIGURE 14. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 15. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 17. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 19. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 23. ANTI-MULLERIAN HORMONE TEST MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. ANTI-MULLERIAN HORMONE TEST MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. ANTI-MULLERIAN HORMONE TEST MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, 2018-2023 (USD THOUSAND)
TABLE 4. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, 2024-2030 (USD THOUSAND)
TABLE 5. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REGION, 2018-2023 (USD THOUSAND)
TABLE 6. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REGION, 2024-2030 (USD THOUSAND)
TABLE 7. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 8. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 9. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY POC TESTING, BY REGION, 2018-2023 (USD THOUSAND)
TABLE 10. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY POC TESTING, BY REGION, 2024-2030 (USD THOUSAND)
TABLE 11. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, BY REGION, 2018-2023 (USD THOUSAND)
TABLE 12. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, BY REGION, 2024-2030 (USD THOUSAND)
TABLE 13. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 14. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 15. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMMERCIAL LABS, BY REGION, 2018-2023 (USD THOUSAND)
TABLE 16. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMMERCIAL LABS, BY REGION, 2024-2030 (USD THOUSAND)
TABLE 17. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2023 (USD THOUSAND)
TABLE 18. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2024-2030 (USD THOUSAND)
TABLE 19. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD THOUSAND)
TABLE 20. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD THOUSAND)
TABLE 21. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY OFFLINE CHANNELS, BY REGION, 2018-2023 (USD THOUSAND)
TABLE 22. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY OFFLINE CHANNELS, BY REGION, 2024-2030 (USD THOUSAND)
TABLE 23. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2023 (USD THOUSAND)
TABLE 24. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2024-2030 (USD THOUSAND)
TABLE 25. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2023 (USD THOUSAND)
TABLE 26. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2024-2030 (USD THOUSAND)
TABLE 27. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY HUMAN, BY REGION, 2018-2023 (USD THOUSAND)
TABLE 28. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY HUMAN, BY REGION, 2024-2030 (USD THOUSAND)
TABLE 29. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY NON-HUMAN PRIMATE, BY REGION, 2018-2023 (USD THOUSAND)
TABLE 30. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY NON-HUMAN PRIMATE, BY REGION, 2024-2030 (USD THOUSAND)
TABLE 31. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 32. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 33. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 34. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 35. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD THOUSAND)
TABLE 36. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD THOUSAND)
TABLE 37. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2023 (USD THOUSAND)
TABLE 38. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2024-2030 (USD THOUSAND)
TABLE 39. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2018-2023 (USD THOUSAND)
TABLE 40. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2024-2030 (USD THOUSAND)
TABLE 41. ARGENTINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 42. ARGENTINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 43. ARGENTINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 44. ARGENTINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 45. ARGENTINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD THOUSAND)
TABLE 46. ARGENTINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD THOUSAND)
TABLE 47. ARGENTINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2023 (USD THOUSAND)
TABLE 48. ARGENTINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2024-2030 (USD THOUSAND)
TABLE 49. BRAZIL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 50. BRAZIL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 51. BRAZIL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 52. BRAZIL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 53. BRAZIL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD THOUSAND)
TABLE 54. BRAZIL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD THOUSAND)
TABLE 55. BRAZIL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2023 (USD THOUSAND)
TABLE 56. BRAZIL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2024-2030 (USD THOUSAND)
TABLE 57. CANADA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 58. CANADA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 59. CANADA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 60. CANADA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 61. CANADA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD THOUSAND)
TABLE 62. CANADA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD THOUSAND)
TABLE 63. CANADA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2023 (USD THOUSAND)
TABLE 64. CANADA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2024-2030 (USD THOUSAND)
TABLE 65. MEXICO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 66. MEXICO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 67. MEXICO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 68. MEXICO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 69. MEXICO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD THOUSAND)
TABLE 70. MEXICO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD THOUSAND)
TABLE 71. MEXICO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2023 (USD THOUSAND)
TABLE 72. MEXICO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2024-2030 (USD THOUSAND)
TABLE 73. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 74. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 75. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 76. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 77. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD THOUSAND)
TABLE 78. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD THOUSAND)
TABLE 79. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2023 (USD THOUSAND)
TABLE 80. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2024-2030 (USD THOUSAND)
TABLE 81. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY STATE, 2018-2023 (USD THOUSAND)
TABLE 82. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY STATE, 2024-2030 (USD THOUSAND)
TABLE 83. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 84. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 85. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 86. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 87. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD THOUSAND)
TABLE 88. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD THOUSAND)
TABLE 89. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2023 (USD THOUSAND)
TABLE 90. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2024-2030 (USD THOUSAND)
TABLE 91. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2018-2023 (USD THOUSAND)
TABLE 92. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2024-2030 (USD THOUSAND)
TABLE 93. AUSTRALIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 94. AUSTRALIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 95. AUSTRALIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 96. AUSTRALIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 97. AUSTRALIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD THOUSAND)
TABLE 98. AUSTRALIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD THOUSAND)
TABLE 99. AUSTRALIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2023 (USD THOUSAND)
TABLE 100. AUSTRALIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2024-2030 (USD THOUSAND)
TABLE 101. CHINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 102. CHINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 103. CHINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 104. CHINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 105. CHINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD THOUSAND)
TABLE 106. CHINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD THOUSAND)
TABLE 107. CHINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2023 (USD THOUSAND)
TABLE 108. CHINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2024-2030 (USD THOUSAND)
TABLE 109. INDIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 110. INDIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 111. INDIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 112. INDIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 113. INDIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD THOUSAND)
TABLE 114. INDIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD THOUSAND)
TABLE 115. INDIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2023 (USD THOUSAND)
TABLE 116. INDIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2024-2030 (USD THOUSAND)
TABLE 117. INDONESIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 118. INDONESIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 119. INDONESIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 120. INDONESIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 121. INDONESIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD THOUSAND)
TABLE 122. INDONESIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD THOUSAND)
TABLE 123. INDONESIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2023 (USD THOUSAND)
TABLE 124. INDONESIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2024-2030 (USD THOUSAND)
TABLE 125. JAPAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 126. JAPAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 127. JAPAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 128. JAPAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 129. JAPAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD THOUSAND)
TABLE 130. JAPAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD THOUSAND)
TABLE 131. JAPAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2023 (USD THOUSAND)
TABLE 132. JAPAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2024-2030 (USD THOUSAND)
TABLE 133. MALAYSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 134. MALAYSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 135. MALAYSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 136. MALAYSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 137. MALAYSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD THOUSAND)
TABLE 138. MALAYSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD THOUSAND)
TABLE 139. MALAYSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2023 (USD THOUSAND)
TABLE 140. MALAYSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2024-2030 (USD THOUSAND)
TABLE 141. PHILIPPINES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 142. PHILIPPINES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 143. PHILIPPINES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 144. PHILIPPINES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 145. PHILIPPINES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD THOUSAND)
TABLE 146. PHILIPPINES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD THOUSAND)
TABLE 147. PHILIPPINES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2023 (USD THOUSAND)
TABLE 148. PHILIPPINES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2024-2030 (USD THOUSAND)
TABLE 149. SINGAPORE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 150. SINGAPORE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 151. SINGAPORE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 152. SINGAPORE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 153. SINGAPORE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD THOUSAND)
TABLE 154. SINGAPORE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD THOUSAND)
TABLE 155. SINGAPORE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2023 (USD THOUSAND)
TABLE 156. SINGAPORE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2024-2030 (USD THOUSAND)
TABLE 157. SOUTH KOREA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 158. SOUTH KOREA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 159. SOUTH KOREA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 160. SOUTH KOREA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 161. SOUTH KOREA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD THOUSAND)
TABLE 162. SOUTH KOREA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD THOUSAND)
TABLE 163. SOUTH KOREA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2023 (USD THOUSAND)
TABLE 164. SOUTH KOREA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2024-2030 (USD THOUSAND)
TABLE 165. TAIWAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 166. TAIWAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 167. TAIWAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 168. TAIWAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 169. TAIWAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD THOUSAND)
TABLE 170. TAIWAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD THOUSAND)
TABLE 171. TAIWAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2023 (USD THOUSAND)
TABLE 172. TAIWAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2024-2030 (USD THOUSAND)
TABLE 173. THAILAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 174. THAILAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 175. THAILAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 176. THAILAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 177. THAILAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD THOUSAND)
TABLE 178. THAILAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD THOUSAND)
TABLE 179. THAILAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2023 (USD THOUSAND)
TABLE 180. THAILAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2024-2030 (USD THOUSAND)
TABLE 181. VIETNAM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 182. VIETNAM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 183. VIETNAM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 184. VIETNAM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 185. VIETNAM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD THOUSAND)
TABLE 186. VIETNAM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD THOUSAND)
TABLE 187. VIETNAM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2023 (USD THOUSAND)
TABLE 188. VIETNAM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2024-2030 (USD THOUSAND)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD THOUSAND)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD THOUSAND)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2023 (USD THOUSAND)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2024-2030 (USD THOUSAND)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2018-2023 (USD THOUSAND)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2024-2030 (USD THOUSAND)
TABLE 199. DENMARK ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 200. DENMARK ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 201. DENMARK ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 202. DENMARK ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 203. DENMARK ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD THOUSAND)
TABLE 204. DENMARK ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD THOUSAND)
TABLE 205. DENMARK ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2023 (USD THOUSAND)
TABLE 206. DENMARK ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2024-2030 (USD THOUSAND)
TABLE 207. EGYPT ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 208. EGYPT ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 209. EGYPT ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 210. EGYPT ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 211. EGYPT ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD THOUSAND)
TABLE 212. EGYPT ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD THOUSAND)
TABLE 213. EGYPT ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2023 (USD THOUSAND)
TABLE 214. EGYPT ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2024-2030 (USD THOUSAND)
TABLE 215. FINLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 216. FINLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 217. FINLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 218. FINLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 219. FINLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD THOUSAND)
TABLE 220. FINLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD THOUSAND)
TABLE 221. FINLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2023 (USD THOUSAND)
TABLE 222. FINLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2024-2030 (USD THOUSAND)
TABLE 223. FRANCE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 224. FRANCE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 225. FRANCE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 226. FRANCE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 227. FRANCE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD THOUSAND)
TABLE 228. FRANCE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD THOUSAND)
TABLE 229. FRANCE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2023 (USD THOUSAND)
TABLE 230. FRANCE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2024-2030 (USD THOUSAND)
TABLE 231. GERMANY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 232. GERMANY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 233. GERMANY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 234. GERMANY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 235. GERMANY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD THOUSAND)
TABLE 236. GERMANY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD THOUSAND)
TABLE 237. GERMANY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2023 (USD THOUSAND)
TABLE 238. GERMANY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2024-2030 (USD THOUSAND)
TABLE 239. ISRAEL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 240. ISRAEL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 241. ISRAEL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 242. ISRAEL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 243. ISRAEL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD THOUSAND)
TABLE 244. ISRAEL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD THOUSAND)
TABLE 245. ISRAEL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2023 (USD THOUSAND)
TABLE 246. ISRAEL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2024-2030 (USD THOUSAND)
TABLE 247. ITALY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 248. ITALY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 249. ITALY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 250. ITALY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 251. ITALY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD THOUSAND)
TABLE 252. ITALY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD THOUSAND)
TABLE 253. ITALY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2023 (USD THOUSAND)
TABLE 254. ITALY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2024-2030 (USD THOUSAND)
TABLE 255. NETHERLANDS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 256. NETHERLANDS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 257. NETHERLANDS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 258. NETHERLANDS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 259. NETHERLANDS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD THOUSAND)
TABLE 260. NETHERLANDS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD THOUSAND)
TABLE 261. NETHERLANDS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2023 (USD THOUSAND)
TABLE 262. NETHERLANDS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2024-2030 (USD THOUSAND)
TABLE 263. NIGERIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 264. NIGERIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 265. NIGERIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 266. NIGERIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 267. NIGERIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD THOUSAND)
TABLE 268. NIGERIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD THOUSAND)
TABLE 269. NIGERIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2023 (USD THOUSAND)
TABLE 270. NIGERIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2024-2030 (USD THOUSAND)
TABLE 271. NORWAY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 272. NORWAY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 273. NORWAY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 274. NORWAY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 275. NORWAY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD THOUSAND)
TABLE 276. NORWAY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD THOUSAND)
TABLE 277. NORWAY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2023 (USD THOUSAND)
TABLE 278. NORWAY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2024-2030 (USD THOUSAND)
TABLE 279. POLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 280. POLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 281. POLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 282. POLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 283. POLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD THOUSAND)
TABLE 284. POLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD THOUSAND)
TABLE 285. POLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2023 (USD THOUSAND)
TABLE 286. POLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2024-2030 (USD THOUSAND)
TABLE 287. QATAR ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 288. QATAR ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 289. QATAR ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 290. QATAR ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 291. QATAR ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD THOUSAND)
TABLE 292. QATAR ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD THOUSAND)
TABLE 293. QATAR ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2023 (USD THOUSAND)
TABLE 294. QATAR ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2024-2030 (USD THOUSAND)
TABLE 295. RUSSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 296. RUSSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 297. RUSSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 298. RUSSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 299. RUSSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD THOUSAND)
TABLE 300. RUSSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD THOUSAND)
TABLE 301. RUSSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2023 (USD THOUSAND)
TABLE 302. RUSSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2024-2030 (USD THOUSAND)
TABLE 303. SAUDI ARABIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 304. SAUDI ARABIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 305. SAUDI ARABIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 306. SAUDI ARABIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 307. SAUDI ARABIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD THOUSAND)
TABLE 308. SAUDI ARABIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD THOUSAND)
TABLE 309. SAUDI ARABIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2023 (USD THOUSAND)
TABLE 310. SAUDI ARABIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2024-2030 (USD THOUSAND)
TABLE 311. SOUTH AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 312. SOUTH AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 313. SOUTH AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 314. SOUTH AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 315. SOUTH AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD THOUSAND)
TABLE 316. SOUTH AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD THOUSAND)
TABLE 317. SOUTH AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2023 (USD THOUSAND)
TABLE 318. SOUTH AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2024-2030 (USD THOUSAND)
TABLE 319. SPAIN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 320. SPAIN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 321. SPAIN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 322. SPAIN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 323. SPAIN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD THOUSAND)
TABLE 324. SPAIN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD THOUSAND)
TABLE 325. SPAIN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2023 (USD THOUSAND)
TABLE 326. SPAIN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2024-2030 (USD THOUSAND)
TABLE 327. SWEDEN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 328. SWEDEN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 329. SWEDEN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 330. SWEDEN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 331. SWEDEN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD THOUSAND)
TABLE 332. SWEDEN ANTI-MULLERIAN HORMONE TE

Companies Mentioned

  • Abbexa Limited
  • Abcam PLC
  • Ansh Labs LLC
  • Athenese-Dx
  • Beckman Coulter, Inc. by Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • bioMérieux S.A.
  • BioVendor – Laboratorni Medicina A.S.
  • Chengdu VACURE Biotechnology Co., Ltd.
  • CTK Biotech, Inc.
  • Cusabio Technology LLC
  • Eagle Biosciences, Inc.
  • Elabscience Bionovation Inc.
  • Epitope Diagnostics, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Fujirebio Europe N.V. by H.U. Group Holdings, Inc.
  • Goldsite Diagnostics Inc.
  • Healthy Human Labs Limited (Vitall)
  • Kamiya Biomedical Company
  • LifeSpan BioSciences, Inc.
  • London Gynaecology Limited
  • Meridian Bioscience, Inc.
  • Monobind Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Tosoh Corporation
  • Vitrosens Biotechnology Co., Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages197
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 305.41 Million
Forecasted Market Value ( USD ) by 2030 $ 586.48 Million
Compound Annual Growth Rate11.4%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Global Endocrine Testing Market by Type (Cortisol Test, Dehydroepiandrosterone Sulfate (DHEAS) Test, Estradiol (E2) Test), Technology (Clinical Chemistry, Immunoassay, Tandem Mass Spectroscopy), Indication, End-User - Forecast 2024-2030 - Product Image

Global Endocrine Testing Market by Type (Cortisol Test, Dehydroepiandrosterone Sulfate (DHEAS) Test, Estradiol (E2) Test), Technology (Clinical Chemistry, Immunoassay, Tandem Mass Spectroscopy), Indication, End-User - Forecast 2024-2030

  • Report
  • 191 Pages
  • Global
From
Global Endocrine Testing Market Size, Share & Trends Analysis Report by Test Type (TSH, hCG Hormone), End-use (Hospitals, Commercial Laboratories), Technology (Immunoassay, Clinical Chemistry), and Segment Forecasts, 2024-2030 - Product Image

Global Endocrine Testing Market Size, Share & Trends Analysis Report by Test Type (TSH, hCG Hormone), End-use (Hospitals, Commercial Laboratories), Technology (Immunoassay, Clinical Chemistry), and Segment Forecasts, 2024-2030

  • Report
  • 180 Pages
  • Global
From
Global Endocrine Testing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Global Endocrine Testing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 132 Pages
  • Global
From
Endocrine Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Endocrine Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 182 Pages
  • Global
From
Egypt Fertility Testing Devices Market Competition Forecast & Opportunities, 2028 - Product Image

Egypt Fertility Testing Devices Market Competition Forecast & Opportunities, 2028

  • Report
  • 77 Pages
  • Egypt
From

About the Anti Mullerian Hormone Test Market

The Anti Mullerian Hormone (AMH) Test is a diagnostic tool used to measure the amount of AMH in a person's blood. AMH is a hormone produced by the ovaries and is used to assess ovarian reserve, or the number of eggs a woman has left in her ovaries. The test is used to help diagnose infertility, polycystic ovary syndrome, and other conditions related to the reproductive system. It is also used to monitor the effectiveness of fertility treatments. The AMH Test market is a growing segment of the diagnostics industry. It is used by fertility clinics, obstetricians, and gynecologists to help diagnose and treat reproductive issues. The test is also used in research studies to better understand the reproductive system. Some companies in the AMH Test market include Beckman Coulter, Roche Diagnostics, Abbott Laboratories, and Siemens Healthineers. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.